833 related articles for article (PubMed ID: 29948360)
21. Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study.
Anderson DJ; Moehring RW; Sloane R; Schmader KE; Weber DJ; Fowler VG; Smathers E; Sexton DJ
PLoS One; 2014; 9(3):e91713. PubMed ID: 24643200
[TBL] [Abstract][Full Text] [Related]
22. ESBL-producing Escherichia coli isolated from bloodstream infections--antimicrobial susceptibility, conjugative transfer of resistance genes and phylogenetic origin.
Franiczek R; Krzyżanowska B
Adv Clin Exp Med; 2014; 23(6):865-70. PubMed ID: 25618110
[TBL] [Abstract][Full Text] [Related]
23. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome.
Dat VQ; Vu HN; Nguyen The H; Nguyen HT; Hoang LB; Vu Tien Viet D; Bui CL; Van Nguyen K; Nguyen TV; Trinh DT; Torre A; van Doorn HR; Nadjm B; Wertheim HFL
BMC Infect Dis; 2017 Jul; 17(1):493. PubMed ID: 28701159
[TBL] [Abstract][Full Text] [Related]
24. Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study.
Hristea A; Olaru ID; Adams-Sapper S; Riley LW
Infect Dis (Lond); 2015 Jan; 47(1):46-51. PubMed ID: 25365029
[TBL] [Abstract][Full Text] [Related]
25. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
26. A multicenter investigation of 2,773 cases of bloodstream infections based on China antimicrobial surveillance network (CHINET).
Hu F; Yuan L; Yang Y; Xu Y; Huang Y; Hu Y; Ai X; Zhuo C; Su D; Shan B; Du Y; Yu Y; Lin J; Sun Z; Chen Z; Xu Y; Zhang X; Wang C; He L; Ni Y; Zhang Y; Lin D; Zhu D; Zhang Y
Front Cell Infect Microbiol; 2022; 12():1075185. PubMed ID: 36590586
[TBL] [Abstract][Full Text] [Related]
27. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections.
Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M
Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600
[TBL] [Abstract][Full Text] [Related]
28. Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: an 11 year experience in Oxfordshire, UK.
Webster DP; Young BC; Morton R; Collyer D; Batchelor B; Turton JF; Maharjan S; Livermore DM; Bejon P; Cookson BD; Bowler IC
J Antimicrob Chemother; 2011 Sep; 66(9):2126-35. PubMed ID: 21693458
[TBL] [Abstract][Full Text] [Related]
29. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
[TBL] [Abstract][Full Text] [Related]
30. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
Wiener J; Quinn JP; Bradford PA; Goering RV; Nathan C; Bush K; Weinstein RA
JAMA; 1999 Feb; 281(6):517-23. PubMed ID: 10022107
[TBL] [Abstract][Full Text] [Related]
31. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Kousouli E; Zarkotou O; Politi L; Polimeri K; Vrioni G; Themeli-Digalaki K; Tsakris A; Pournaras S
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):43-50. PubMed ID: 28879405
[TBL] [Abstract][Full Text] [Related]
32. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
34. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
35. Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Bandy A; Almaeen AH
PLoS One; 2020; 15(6):e0233704. PubMed ID: 32516308
[TBL] [Abstract][Full Text] [Related]
36. High Burden of Extended-Spectrum β-Lactamase-Producing
Sawatwong P; Sapchookul P; Whistler T; Gregory CJ; Sangwichian O; Makprasert S; Jorakate P; Srisaengchai P; Thamthitiwat S; Promkong C; Nanvatthanachod P; Vanaporn M; Rhodes J
Am J Trop Med Hyg; 2019 Apr; 100(4):943-951. PubMed ID: 30793684
[TBL] [Abstract][Full Text] [Related]
37. Bacteremia Caused by Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in Vientiane, Lao PDR: A 5-Year Study.
Chang K; Rattanavong S; Mayxay M; Keoluangkhot V; Davong V; Vongsouvath M; Luangraj M; Simpson AJH; Newton PN; Dance DAB
Am J Trop Med Hyg; 2020 May; 102(5):1137-1143. PubMed ID: 32157990
[TBL] [Abstract][Full Text] [Related]
38. [Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].
Ferrández O; Grau S; Saballs P; Luque S; Terradas R; Salas E
Rev Clin Esp; 2011 Mar; 211(3):119-26. PubMed ID: 21371702
[TBL] [Abstract][Full Text] [Related]
39. Burn-associated bloodstream infections in pediatric burn patients: Time distribution of etiologic agents.
Devrim İ; Kara A; Düzgöl M; Karkıner A; Bayram N; Temir G; Şencan A; Sorguç Y; Gülfidan G; Hoşgör M
Burns; 2017 Feb; 43(1):144-148. PubMed ID: 27615546
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology, Risk Factors, and Clinical Outcomes of Bloodstream Infection due to Extended-Spectrum Beta-Lactamase-Producing
Liang T; Xu C; Cheng Q; Tang Y; Zeng H; Li X
Microb Drug Resist; 2021 Jun; 27(6):800-808. PubMed ID: 33232654
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
